new glp 1 gip drug TrimRX The GLP-1 revolution: What UAB
Description
doi: 10.4158/CS-2018-0535
Each study was assessed across key domains, including clarity of objectives, eligibility criteria, sample size justification, outcome measurement, blinding (if applicable), and adequacy of statistical analyses
Int J Obes 37(11):14431451
And despite a hefty $1.8 billion investment into long Covid research under the Biden administration, progress on finding effective treatments has been slow
It suggests that the benefits in terms of MACE, hospitalization for heart failure, and progression of chronic kidney disease (composite outcome) from SGLT2is occur independently of the use of GLP1-RAs
